Socorro buys LM 49: Pfizer : Announces Detailed Results For Phase 3 OPT Retreatment Study Of Tofacitinib In Adults With Moderate-To-Severe Chronic P ...
Release date- 26052014 - Pfizer Inc. (NYSE:PFE) announced today detailed results from the ... 2012;7:385-422. 9 Johnson-Huang LM, Lowes MA, Krueger JG. Putting together the psoriasis puzzle: an update on developing targeted therapies. ...
40 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home